ITGR Quote, Financials, Valuation and Earnings

AngioDynamics has a net margin of -5.14% compared to Integer Holdings's net margin of -6.12%. Integer Holdings's return on equity of 4.85% beat AngioDynamics's return on equity of -20.83%.

Integer Holdings has a consensus price target of $148.75, signalling upside risk potential of 25.25%. On the other hand AngioDynamics has an analysts' consensus of $15.67 which suggests that it could grow by 53.6%. Given that AngioDynamics has higher upside potential than Integer Holdings, analysts believe AngioDynamics is more attractive than Integer Holdings.

Integer Holdings has a beta of 0.979, which suggesting that the stock is 2.088% less volatile than S&P 500. In comparison AngioDynamics has a beta of 0.619, suggesting its less volatile than the S&P 500 by 38.149%.

Integer Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AngioDynamics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Integer Holdings pays -- of its earnings as a dividend. AngioDynamics pays out -- of its earnings as a dividend.

Integer Holdings quarterly revenues are $437.4M, which are larger than AngioDynamics quarterly revenues of $72M. Integer Holdings's net income of -$22.5M is lower than AngioDynamics's net income of -$4.4M. Notably, Integer Holdings's price-to-earnings ratio is 56.28x while AngioDynamics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Integer Holdings is 2.39x versus 1.47x for AngioDynamics. Usually stocks with elevated PS ratios are considered overvalued.

Becton Dickinson & has a net margin of -5.14% compared to Integer Holdings's net margin of 5.84%. Integer Holdings's return on equity of 4.85% beat Becton Dickinson &'s return on equity of 5.86%.

Integer Holdings has a consensus price target of $148.75, signalling upside risk potential of 25.25%. On the other hand Becton Dickinson & has an analysts' consensus of $222.96 which suggests that it could grow by 29.19%. Given that Becton Dickinson & has higher upside potential than Integer Holdings, analysts believe Becton Dickinson & is more attractive than Integer Holdings.

Integer Holdings has a beta of 0.979, which suggesting that the stock is 2.088% less volatile than S&P 500. In comparison Becton Dickinson & has a beta of 0.251, suggesting its less volatile than the S&P 500 by 74.889%.

Integer Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Becton Dickinson & offers a yield of 2.31% to investors and pays a quarterly dividend of $1.04 per share. Integer Holdings pays -- of its earnings as a dividend. Becton Dickinson & pays out 64.52% of its earnings as a dividend. Becton Dickinson &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Integer Holdings quarterly revenues are $437.4M, which are smaller than Becton Dickinson & quarterly revenues of $5.3B. Integer Holdings's net income of -$22.5M is lower than Becton Dickinson &'s net income of $308M. Notably, Integer Holdings's price-to-earnings ratio is 56.28x while Becton Dickinson &'s PE ratio is 32.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Integer Holdings is 2.39x versus 2.40x for Becton Dickinson &. Usually stocks with elevated PS ratios are considered overvalued.

Boston Scientific has a net margin of -5.14% compared to Integer Holdings's net margin of 14.45%. Integer Holdings's return on equity of 4.85% beat Boston Scientific's return on equity of 9.57%.

Integer Holdings has a consensus price target of $148.75, signalling upside risk potential of 25.25%. On the other hand Boston Scientific has an analysts' consensus of $116.96 which suggests that it could grow by 11.12%. Given that Integer Holdings has higher upside potential than Boston Scientific, analysts believe Integer Holdings is more attractive than Boston Scientific.

Integer Holdings has a beta of 0.979, which suggesting that the stock is 2.088% less volatile than S&P 500. In comparison Boston Scientific has a beta of 0.681, suggesting its less volatile than the S&P 500 by 31.908%.

Integer Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Integer Holdings pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.

Integer Holdings quarterly revenues are $437.4M, which are smaller than Boston Scientific quarterly revenues of $4.7B. Integer Holdings's net income of -$22.5M is lower than Boston Scientific's net income of $674M. Notably, Integer Holdings's price-to-earnings ratio is 56.28x while Boston Scientific's PE ratio is 76.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Integer Holdings is 2.39x versus 8.93x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

Globus Medical has a net margin of -5.14% compared to Integer Holdings's net margin of 12.62%. Integer Holdings's return on equity of 4.85% beat Globus Medical's return on equity of 4.59%.

Integer Holdings has a consensus price target of $148.75, signalling upside risk potential of 25.25%. On the other hand Globus Medical has an analysts' consensus of $85.17 which suggests that it could grow by 43.91%. Given that Globus Medical has higher upside potential than Integer Holdings, analysts believe Globus Medical is more attractive than Integer Holdings.

Integer Holdings has a beta of 0.979, which suggesting that the stock is 2.088% less volatile than S&P 500. In comparison Globus Medical has a beta of 1.202, suggesting its more volatile than the S&P 500 by 20.197%.

Integer Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Globus Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Integer Holdings pays -- of its earnings as a dividend. Globus Medical pays out -- of its earnings as a dividend.

Integer Holdings quarterly revenues are $437.4M, which are smaller than Globus Medical quarterly revenues of $598.1M. Integer Holdings's net income of -$22.5M is lower than Globus Medical's net income of $75.5M. Notably, Integer Holdings's price-to-earnings ratio is 56.28x while Globus Medical's PE ratio is 44.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Integer Holdings is 2.39x versus 3.27x for Globus Medical. Usually stocks with elevated PS ratios are considered overvalued.